{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:22:56Z","timestamp":1790821376572,"version":"4.1.0"},"reference-count":144,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:00:00Z","timestamp":1724371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Istituto Superiore di Sanit\u00e0 (Rome, Italy)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Hematological malignancies refer to a heterogeneous group of neoplastic conditions of lymphoid and hematopoietic tissues classified in leukemias, Hodgkin and non-Hodgkin lymphomas and multiple myeloma, according to their presumed cell of origin, genetic abnormalities, and clinical features. Metabolic adaptation and immune escape, which influence various cellular functions, including the proliferation and survival of hematological malignant tumor cells, are major aspects of these malignancies that lead to therapeutic drug resistance. Targeting specific metabolic pathways is emerging as a novel therapeutic strategy in hematopoietic neoplasms, particularly in acute myeloid leukemia and multiple myeloma. In this context, CD147, also known as extracellular matrix metalloproteinase inducer (EMMPRIN) or Basigin, is one target candidate involved in reprograming metabolism in different cancer cells, including hematological malignant tumor cells. CD147 overexpression significantly contributes to the metabolic transformation of these cancer cells, by mediating signaling pathway, growth, metastasis and metabolic reprogramming, through its interaction, direct or not, with various membrane proteins related to metabolic regulation, including monocarboxylate transporters, integrins, P-glycoprotein, and glucose transporter 1. This review explores the metabolic functions of CD147 and its impact on the tumor microenvironment, influencing the progression and neoplastic transformation of leukemias, myeloma, and lymphomas. Furthermore, we highlight new opportunities for the development of targeted therapies against CD147, potentially improving the treatment of hematologic malignancies.<\/jats:p>","DOI":"10.3390\/ijms25179178","type":"journal-article","created":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T05:16:24Z","timestamp":1724649384000},"page":"9178","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Metabolic Function and Therapeutic Potential of CD147 for Hematological Malignancies: An Overview"],"prefix":"10.3390","volume":"25","author":[{"given":"Isabella","family":"Spinello","sequence":"first","affiliation":[{"name":"Istituto Superiore di Sanit\u00e0, National Center for Drug Research and Evaluation, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Labbaye","sequence":"additional","affiliation":[{"name":"Istituto Superiore di Sanit\u00e0, National Center for Drug Research and Evaluation, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6681-6887","authenticated-orcid":false,"given":"Ernestina","family":"Saulle","sequence":"additional","affiliation":[{"name":"Istituto Superiore di Sanit\u00e0, National Center for Drug Research and Evaluation, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,23]]},"reference":[{"key":"ref_1","first-page":"151","article-title":"Hematological malignancies: Disease pathophysiology of leukemic stem cells","volume":"8","author":"Ramdass","year":"2013","journal-title":"J. Stem Cells"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1182\/blood-2017-02-734541","article-title":"Diagnosis and classification of hematologic malignancies on the basis of genetics","volume":"130","author":"Taylor","year":"2017","journal-title":"Blood"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: Integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Traba, J., Sack, M.N., Waldmann, T.A., and Anton, O.M. (2021). Immunometabolism at the Nexus of Cancer Therapeutic Efficacy and Resistance. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.657293"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e840","DOI":"10.1016\/S2352-3026(21)00241-6","article-title":"A comprehensive approach to therapy of haematological malignancies in older patients","volume":"8","author":"Cordoba","year":"2021","journal-title":"Lancet Haematol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41392-023-01521-5","article-title":"Immunotherapy in hematologic malignancies: Achievements, challenges and future prospects","volume":"8","author":"Tang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Sochacka-Cwik\u0142a, A., Maczynski, M., and Regiec, A. (2022). FDA-Approved Drugs for Hematological Malignancies\u2014The Last Decade Review. Cancers, 14.","DOI":"10.3390\/cancers14010087"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1158\/0008-5472.CAN-22-0917","article-title":"Metabolic Reprogramming in Hematologic Malignancies: Advances and Clinical Perspectives","volume":"82","author":"Yu","year":"2022","journal-title":"Cancer Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41573-021-00339-6","article-title":"Targeting cancer metabolism in the era of precision oncology","volume":"21","author":"Stine","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_12","first-page":"119","article-title":"Reexamining cancer metabolism: Lactate production for carcinogenesis could be the purpose and explanation of the Warburg Effect","volume":"38","author":"Brooks","year":"2017","journal-title":"Carcinogenesis"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.yexmp.2007.08.014","article-title":"CD147 immunoglobulin superfamily receptor function and role in pathology","volume":"83","author":"Iacono","year":"2007","journal-title":"Exp. Mol. Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/jb\/mvv127","article-title":"Basigin (CD147), a multifunctional transmembrane glycoprotein with various binding partners","volume":"159","author":"Muramatsu","year":"2016","journal-title":"J. Biochem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3324\/haematol.2018.199661","article-title":"The small-molecule compound AC-73 targeting CD147 inhibits leukemic cell proliferation, induces autophagy and increases the chemotherapeutic sensitivity of acute myeloid leukemia cells","volume":"104","author":"Spinello","year":"2019","journal-title":"Haematologica"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Nyalali, A.M.K., Leonard, A.U., Xu, Y., Li, H., Zhou, J., Zhang, X., Rugambwa, T.K., Shi, X., and Li, F. (2023). CD147: An integral and potential molecule to abrogate hallmarks of cancer. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1238051"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nm.3867","article-title":"The Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cells","volume":"21","author":"Zhu","year":"2015","journal-title":"Nat. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"17411","DOI":"10.3390\/ijms151017411","article-title":"The biological function and clinical utilization of CD147 in human diseases: A review of the current scientific literature","volume":"15","author":"Xiong","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nm.4128","article-title":"Immunomodulatory drugs disrupt the cereblon-CD147-MCT1 axis to exert anti-tumor activity and teratogenicity","volume":"22","author":"Eichner","year":"2016","journal-title":"Nat. Med."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Landras, A., Reger de Moura, C., Jouenne, F., Lebbe, C., Menashi, S., and Mourah, S. (2019). CD147 Is a Promising Target of Tumor Progression and a Prognostic Biomarker. Cancers, 11.","DOI":"10.3390\/cancers11111803"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/ecco-jcc\/jjac084","article-title":"CD147 Targeting by AC-73 Induces Autophagy and Reduces Intestinal Fibrosis Associated with TNBS Chronic Colitis","volume":"16","author":"Butera","year":"2022","journal-title":"J. Crohns Colitis"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Chuli\u00e1-Peris, L., Carreres-Rey, C., Gabasa, M., Alcaraz, J., Carretero, J., and Pereda, J. (2022). Matrix Metalloproteinases and Their Inhibitors in Pulmonary Fibrosis: EMMPRIN\/CD147 Comes into Play. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23136894"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"6360","DOI":"10.1073\/pnas.111583198","article-title":"CD147 facilitates HIV-1 infection by interacting with virus-associated cyclophilin A","volume":"98","author":"Pushkarsky","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Spinello, I., Saulle, E., Quaranta, M.T., Pelosi, E., Castelli, G., Cerio, A., Pasquini, L., Morsilli, O., Dupuis, M.L., and Labbaye, C. (2024). AC-73 and Syrosingopine Inhibit SARS-CoV-2 Entry into Megakaryocytes by Targeting CD147 and MCT4. Viruses, 16.","DOI":"10.3390\/v16010082"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrc3982","article-title":"Glycosylation in cancer: Mechanisms and clinical implications","volume":"15","author":"Pinho","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/path.5054","article-title":"N-glycosylation by N-acetylglucosaminyltransferase V enhances the interaction of CD147\/basigin with integrin \u03b21 and promotes HCC metastasis","volume":"245","author":"Cui","year":"2018","journal-title":"J. Pathol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Li, W., Wang, D., Ge, Y., Zhang, L., Wu, J., and Liu, D. (2020). Discovery and Biological Evaluation of CD147 N-Glycan Inhibitors: A New Direction in the Treatment of Tumor Metastasis. Molecules, 26.","DOI":"10.3390\/molecules26010033"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1681\/ASN.2008090957","article-title":"The E-selectin ligand basigin\/CD147 is responsible for neutrophil recruitment in renal ischemia\/reperfusion","volume":"20","author":"Kato","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"6356","DOI":"10.3390\/ijms15046356","article-title":"Importance of N-glycosylation on CD147 for its biological functions","volume":"15","author":"Bai","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1091\/mbc.e04-05-0402","article-title":"Links between CD147 function, glycosylation, and caveolin-1","volume":"15","author":"Tang","year":"2004","journal-title":"Mol. Biol. Cell"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.biocel.2012.04.026","article-title":"Glycomic alterations are associated with multidrug resistance in human leukemia","volume":"44","author":"Zhang","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/j.1365-2141.2008.07296.x","article-title":"The role of BSG (CD147) in acute lymphoblastic leukaemia and relapse","volume":"142","author":"Beesley","year":"2008","journal-title":"Br. J. Haematol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"17805","DOI":"10.1074\/jbc.M801876200","article-title":"Basigin-2 is a cell surface receptor for soluble basigin ligand","volume":"283","author":"Belton","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.bbrc.2012.02.049","article-title":"Dimerization is essential for HAb18G\/CD147 promoting tumor invasion via MAPK pathway","volume":"419","author":"Cui","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/sj.onc.1207070","article-title":"The microvesicle as a vehicle for EMMPRIN in tumor-stromal interactions","volume":"23","author":"Sidhu","year":"2004","journal-title":"Oncogene"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/jgh.13148","article-title":"Circulating CD147 predicts mortality in advanced hepatocellular carcinoma","volume":"31","author":"Lee","year":"2016","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_37","first-page":"252","article-title":"Plasma soluble cluster of differentiation 147 levels are increased in breast cancer patients and associated with lymph node metastasis and chemoresistance","volume":"24","author":"Kuang","year":"2018","journal-title":"Hong Kong Med. J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.7150\/thno.30714","article-title":"Soluble EMMPRIN levels discriminate aortic ectasia in Marfan syndrome patients","volume":"9","author":"Rurali","year":"2019","journal-title":"Theranostics"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"\u0141acina, P., Butrym, A., Turlej, E., Stachowicz-Suhs, M., Wietrzyk, J., Mazur, G., and Bogunia-Kubik, K. (2022). BSG (CD147) Serum Level and Genetic Variants Are Associated with Overall Survival in Acute Myeloid Leukaemia. J. Clin. Med., 11.","DOI":"10.3390\/jcm11020332"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3390\/cimb44010026","article-title":"Soluble CD147 (BSG) as a Prognostic Marker in Multiple Myeloma","volume":"44","author":"Butrym","year":"2022","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"847","DOI":"10.4049\/jimmunol.149.3.847","article-title":"Human leukocyte activation antigen M6, a member of the Ig superfamily, is the species homologue of rat OX-47, mouse basigin, and chicken HT7 molecule","volume":"149","author":"Kasinrerk","year":"1992","journal-title":"J. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Saulle, E., Spinello, I., Quaranta, M.T., Pasquini, L., Pelosi, E., Iorio, E., Castelli, G., Chirico, M., Pisanu, M.E., and Ottone, T. (2021). Targeting Lactate Metabolism by Inhibiting MCT1 or MCT4 Impairs Leukemic Cell Proliferation, Induces Two Different Related Death-Pathways and Increases Chemotherapeutic Sensitivity of Acute Myeloid Leukemia Cells. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.621458"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Zou, S., Parfenova, E., Vrdoljak, N., Minden, M.D., and Spagnuolo, P.A. (2024). Pseudolaric Acid B Targets CD147 to Selectively Kill Acute Myeloid Leukemia Cells. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25126517"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/labinvest.2017.54","article-title":"EMMPRIN (CD147) is induced by C\/EBP\u03b2 and is differentially expressed in ALK+ and ALK- anaplastic large-cell lymphoma","volume":"97","author":"Schmidt","year":"2017","journal-title":"Lab. Investig."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/leu.2016.389","article-title":"PKM2 and other key regulators of Warburg effect positively correlate with CD147 (EMMPRIN) gene expression and predict survival in multiple myeloma","volume":"31","author":"Panchabhai","year":"2017","journal-title":"Leukemia"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1023\/A:1021350718226","article-title":"EMMPRIN-mediated MMP regulation in tumor and endothelial cells","volume":"19","author":"Caudroy","year":"2002","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Ghandour, F., Kassem, S., Simanovich, E., and Rahat, M.A. (2024). Glucose Promotes EMMPRIN\/CD147 and the Secretion of Pro-Angiogenic Factors in a Co-Culture System of Endothelial Cells and Monocytes. Biomedicines, 12.","DOI":"10.3390\/biomedicines12040706"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Kanekura, T. (2023). CD147\/Basigin Is Involved in the Development of Malignant Tumors and T-Cell-Mediated Immunological Disorders via Regulation of Glycolysis. Int. J. Mol. Sci., 24.","DOI":"10.20944\/preprints202311.0767.v1"},{"key":"ref_49","first-page":"2945","article-title":"CD147-mediated reprogrammed glycolytic metabolism potentially induces immune escape in the tumor microenvironment (Review)","volume":"41","author":"Li","year":"2019","journal-title":"Oncol. Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1093\/emboj\/19.15.3896","article-title":"CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression","volume":"19","author":"Kirk","year":"2000","journal-title":"EMBO J."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/iub.573","article-title":"The monocarboxylate transporter family\u2014Structure and functional characterization","volume":"64","author":"Halestrap","year":"2012","journal-title":"IUBMB Life"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.cell.2015.03.023","article-title":"Rod-derived cone viability factor promotes cone survival by stimulating aerobic glycolysis","volume":"161","author":"Fridlich","year":"2015","journal-title":"Cell"},{"key":"ref_53","first-page":"1029","article-title":"GLUT1, MCT1\/4 and CD147 overexpression supports the metabolic reprogramming in papillary renal cell carcinoma","volume":"32","author":"Almeida","year":"2017","journal-title":"Histol. Histopathol."},{"key":"ref_54","first-page":"1651","article-title":"Co-expression of CD147 and GLUT-1 indicates radiation resistance and poor prognosis in cervical squamous cell carcinoma","volume":"7","author":"Huang","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"64778","DOI":"10.18632\/oncotarget.11415","article-title":"CD147 silencing inhibits tumor growth by suppressing glucose transport in melanoma","volume":"7","author":"Su","year":"2016","journal-title":"Oncotarget"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1182\/bloodadvances.2023009967","article-title":"Combined GLUT1 and OXPHOS inhibition eliminates acute myeloid leukemia cells by restraining their metabolic plasticity","volume":"7","author":"Ramakrishnan","year":"2023","journal-title":"Blood Adv."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Hartmann, S., Agostinelli, C., Diener, J., D\u00f6ring, C., Fanti, S., Zinzani, P.L., Gallamini, A., Bergmann, L., Pileri, S., and Hansmann, M.L. (2012). GLUT1 expression patterns in different Hodgkin lymphoma subtypes and progressively transformed germinal centers. BMC Cancer, 12.","DOI":"10.1186\/1471-2407-12-586"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3727\/096504009787721177","article-title":"Relationship between FDG uptake and expressions of glucose transporter type 1, type 3, and hexokinase-II in Reed-Sternberg cells of Hodgkin lymphoma","volume":"17","author":"Shim","year":"2009","journal-title":"Oncol. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1182\/blood-2011-09-377846","article-title":"Multiple myeloma exhibits novel dependence on GLUT4, GLUT8, and GLUT11: Implications for glucose transporter-directed therapy","volume":"119","author":"McBrayer","year":"2012","journal-title":"Blood"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.leukres.2015.12.008","article-title":"Inhibition of glucose transporter 1 induces apoptosis and sensitizes multiple myeloma cells to conventional chemotherapeutic agents","volume":"41","author":"Matsumoto","year":"2016","journal-title":"Leuk. Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"29174","DOI":"10.1074\/jbc.272.46.29174","article-title":"Generation of monoclonal antibodies to integrin-associated proteins. Evidence that alpha 3 beta1 complexes with EMMPRIN\/basigin\/OX47\/M6","volume":"272","author":"Berditchevski","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1074\/mcp.M400207-MCP200","article-title":"Metabolic activation-related CD147-CD98 complex","volume":"4","author":"Xu","year":"2005","journal-title":"Mol. Cell Proteom."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ccell.2016.10.003","article-title":"CD98-Mediated Adhesive Signaling Enables the Establishment and Propagation of Acute Myelogenous Leukemia","volume":"30","author":"Bajaj","year":"2016","journal-title":"Cancer Cell"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s002320001017","article-title":"Surface antigen CD98 (4F2): Not a single membrane protein, but a family of proteins with multiple functions","volume":"173","author":"Boyd","year":"2000","journal-title":"J. Membr. Biol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"eaax7706","DOI":"10.1126\/scitranslmed.aax7706","article-title":"Selective targeting of multiple myeloma cells with a monoclonal antibody recognizing the ubiquitous protein CD98 heavy chain","volume":"14","author":"Hasegawa","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/ijc.29415","article-title":"Antitumor activity of an anti-CD98 antibody","volume":"137","author":"Hayes","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2249.2010.04115.x","article-title":"Cyclophilin-CD147 interactions: A new target for anti-inflammatory therapeutics","volume":"160","author":"Yurchenko","year":"2010","journal-title":"Clin. Exp. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"22959","DOI":"10.1074\/jbc.M201593200","article-title":"Active site residues of cyclophilin A are crucial for its signaling activity via CD147","volume":"277","author":"Yurchenko","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000151225","article-title":"Interaction between CD147 and P-glycoprotein and their regulation by ubiquitination in breast cancer cells","volume":"54","author":"Wang","year":"2008","journal-title":"Chemotherapy"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1160\/TH08-06-0368","article-title":"EMMPRIN (CD147) is a novel receptor for platelet GPVI and mediates platelet rolling via GPVI-EMMPRIN interaction","volume":"101","author":"Seizer","year":"2009","journal-title":"Thromb. Haemost."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1182\/blood-2014-02-554204","article-title":"A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value","volume":"124","author":"Chen","year":"2014","journal-title":"Blood"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Papadopoulou, M.T., Panagopoulou, P., Paramera, E., Pechlivanis, A., Virgiliou, C., Papakonstantinou, E., Palabougiouki, M., Ioannidou, M., Vasileiou, E., and Tragiannidis, A. (2024). Metabolic Fingerprint in Childhood Acute Lymphoblastic Leukemia. Diagnostics, 14.","DOI":"10.3390\/diagnostics14070682"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1158\/0008-5472.CAN-14-3400","article-title":"Metabolic signature identifies novel targets for drug resistance in multiple myeloma","volume":"75","author":"Maiso","year":"2015","journal-title":"Cancer Res."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Balaian, E., Wobus, M., Bornh\u00e4user, M., Chavakis, T., and Sockel, K. (2021). Myelodysplastic Syndromes and Metabolism. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222011250"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/s43440-023-00504-1","article-title":"The Warburg effect: A score for many instruments in the concert of cancer and cancer niche cells","volume":"75","author":"Jaworska","year":"2023","journal-title":"Pharmacol. Rep."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg Effect: How Does It Benefit Cancer Cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/cr.2017.155","article-title":"Mitochondrial metabolism and cancer","volume":"28","author":"Porporato","year":"2018","journal-title":"Cell Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1111\/jcmm.13737","article-title":"Signalling mechanisms that regulate metabolic profile and autophagy of acute myeloid leukaemia cells","volume":"22","author":"Pereira","year":"2018","journal-title":"J. Cell Mol. Med."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Chapuis, N., Poulain, L., Birsen, R., Tamburini, J., and Bouscary, D. (2019). Rationale for Targeting Deregulated Metabolic Pathways as a Therapeutic Strategy in Acute Myeloid Leukemia. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.00405"},{"key":"ref_80","first-page":"6700","article-title":"EMMPRIN is an emerging protein capable of regulating cancer hallmarks","volume":"26","year":"2022","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"6742","DOI":"10.18632\/oncotarget.14272","article-title":"CD147: A small molecule transporter ancillary protein at the crossroad of multiple hallmarks of cancer and metabolic reprogramming","volume":"8","author":"Kendrick","year":"2017","journal-title":"Oncotarget"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(23)00108-3","article-title":"Acute myeloid leukaemia","volume":"401","author":"Erba","year":"2023","journal-title":"Lancet"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1182\/blood.2022018092","article-title":"Metabolism in acute myeloid leukemia: Mechanistic insights and therapeutic targets","volume":"141","author":"Mishra","year":"2023","journal-title":"Blood"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Gr\u00f8nnings\u00e6ter, I.S., Reikvam, H., Aaseb\u00f8, E., Bartaula-Brevik, S., Tvedt, T.H., Bruserud, \u00d8., and Hatfield, K.J. (2020). Targeting Cellular Metabolism in Acute Myeloid Leukemia and The Role of Patient Heterogeneity. Cells, 9.","DOI":"10.3390\/cells9051155"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1182\/blood.V120.21.4318.4318","article-title":"The Expression Profile of Glycolysis Associated Molecules and Chemoresistance in Acute Myeloid Leukemia","volume":"120","author":"Kui","year":"2012","journal-title":"Blood"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3892\/ol.2016.4600","article-title":"Resistance to chemotherapy is associated with altered glucose metabolism in acute myeloid leukemia","volume":"12","author":"Song","year":"2016","journal-title":"Oncol. Lett."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1182\/blood.V98.2.374","article-title":"The functional interactions between CD98, beta1-integrins, and CD147 in the induction of U937 homotypic aggregation","volume":"98","author":"Cho","year":"2001","journal-title":"Blood"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"9700","DOI":"10.1074\/jbc.M115.704254","article-title":"Amino Acid Transport Associated to Cluster of Differentiation 98 Heavy Chain (CD98hc) Is at the Cross-road of Oxidative Stress and Amino Acid Availability","volume":"291","author":"Bial","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.1111\/febs.16818","article-title":"Metformin exerts antileukemic effects by modulating lactate metabolism and overcomes imatinib resistance in chronic myelogenous leukemia","volume":"290","author":"Gayatri","year":"2023","journal-title":"FEBS J."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"3552793","DOI":"10.1155\/2022\/3552793","article-title":"Novel Antibody Exerts Antitumor Effect through Downregulation of CD147 and Activation of Multiple Stress Signals","volume":"2022","author":"Fukuchi","year":"2022","journal-title":"J. Oncol."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Momotow, J., Borchmann, S., Eichenauer, D.A., Engert, A., and Sasse, S. (2021). Hodgkin Lymphoma-Review on Pathogenesis, Diagnosis, Current and Future Treatment Approaches for Adult Patients. J. Clin. Med., 10.","DOI":"10.3390\/jcm10051125"},{"key":"ref_92","first-page":"k3204","article-title":"Non-Hodgkin lymphoma","volume":"362","author":"Ajithkumar","year":"2018","journal-title":"BMJ"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Kluckova, K., D\u2019Avola, A., and Riches, J.C. (2022). Advances in Understanding of Metabolism of B-Cell Lymphoma: Implications for Therapy. Cancers, 14.","DOI":"10.3390\/cancers14225552"},{"key":"ref_94","first-page":"1983","article-title":"EMMPRIN (CD147) is expressed in Hodgkin\u2019s lymphoma and anaplastic large cell lymphoma. An immunohistochemical study of 60 cases","volume":"22","author":"Thorns","year":"2002","journal-title":"Anticancer Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/path.1518","article-title":"Emmprin, a cell surface inducer of matrix metalloproteinases (MMPs), is expressed in T-cell lymphomas","volume":"202","author":"Nabeshima","year":"2004","journal-title":"J. Pathol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1038\/s41375-022-01617-x","article-title":"CD147 a direct target of miR-146a supports energy metabolism and promotes tumor growth in ALK + ALCL","volume":"36","author":"Steinhilber","year":"2022","journal-title":"Leukemia"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1080\/07357900701867892","article-title":"Inhibition of CD147 gene expression via RNA interference reduces tumor cell proliferation, activation, adhesion, and migration activity in the human Jurkat T-lymphoma cell line","volume":"26","author":"Chen","year":"2008","journal-title":"Cancer Investig."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Sakamoto, M., Miyagaki, T., Kamijo, H., Oka, T., Boki, H., Takahashi-Shishido, N., Suga, H., Sugaya, M., and Sato, S. (2021). CD147-Cyclophilin a Interactions Promote Proliferation and Survival of Cutaneous T-Cell Lymphoma. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22157889"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41572-024-00525-x","article-title":"Acute lymphoblastic leukaemia","volume":"10","author":"Pagliaro","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nature21076","article-title":"Metabolic gatekeeper function of B-lymphoid transcription factors","volume":"542","author":"Chan","year":"2017","journal-title":"Nature"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.molimm.2015.07.034","article-title":"Glucose, glycolysis and lymphocyte responses","volume":"68 Pt C","author":"Donnelly","year":"2015","journal-title":"Mol. Immunol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1182\/blood-2017-02-769851","article-title":"S100-A9 protein in exosomes from chronic lymphocytic leukemia cells promotes NF-kappaB activity during disease progression","volume":"130","author":"Prieto","year":"2017","journal-title":"Blood"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"102405","DOI":"10.1016\/j.bcmd.2020.102405","article-title":"Tumor-stroma interaction increases CD147 expression in neoplastic B lymphocytes in chronic lymphocytic leukemia","volume":"82","author":"Rodriguez","year":"2020","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.3324\/haematol.2020.247015","article-title":"Multiple myeloma: The (r)evolution of current therapy and a glance into future","volume":"105","author":"Gulla","year":"2020","journal-title":"Haematologica"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41375-021-01453-5","article-title":"Mortality trends in multiple myeloma after the introduction of novel therapies in the United States","volume":"36","author":"Binder","year":"2022","journal-title":"Leukemia"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jama.2022.14578","article-title":"Diagnosis and Treatment of Myelodysplastic Syndromes: A Review","volume":"328","author":"Sekeres","year":"2022","journal-title":"JAMA"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Gerke, M.B., Christodoulou, I., and Karantanos, T. (2023). Definitions, Biology, and Current Therapeutic Landscape of Myelodysplastic\/Myeloproliferative Neoplasms. Cancers, 15.","DOI":"10.3390\/cancers15153815"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.4161\/cc.26193","article-title":"CD147 regulates the expression of MCT1 and lactate export in multiple myeloma cells","volume":"12","author":"Walters","year":"2013","journal-title":"Cell Cycle"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1038\/leu.2012.91","article-title":"Increased expression of extracellular matrix metalloproteinase inducer (CD147) in multiple myeloma: Role in regulation of myeloma cell proliferation","volume":"26","author":"Arendt","year":"2012","journal-title":"Leukemia"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"\u0141acina, P., Butrym, A., Mazur, G., and Bogunia-Kubik, K. (2018). BSG and MCT1 Genetic Variants Influence Survival in Multiple Myeloma Patients. Genes, 9.","DOI":"10.3390\/genes9050226"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ajh.24634","article-title":"IKAROS expression in distinct bone marrow cell populations as a candidate biomarker for outcome with lenalidomide-dexamethasone therapy in multiple myeloma","volume":"92","author":"Bolomsky","year":"2017","journal-title":"Am. J. Hematol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/nm.2969","article-title":"The vascular niche E-selectin regulates hematopoietic stem cell dormancy, self-renewal and chemoresistance","volume":"18","author":"Winkler","year":"2012","journal-title":"Nat. Med."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nature11926","article-title":"CXCL12 in early mesenchymal progenitors is required for the maintenance of hematopoietic stem cells","volume":"495","author":"Greenbaum","year":"2013","journal-title":"Nature"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.immuni.2006.10.016","article-title":"Maintenance of hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches","volume":"25","author":"Sugiyama","year":"2006","journal-title":"Immunity"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.cell.2014.07.048","article-title":"Specific metabolic dependence of cell status in hematopoiesis and leukemogenesis","volume":"158","author":"Wang","year":"2014","journal-title":"Cell"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.stem.2015.08.019","article-title":"AMPK protects the cells that initiate leukemia in myeloid leukemias from metabolic stress in the bone marrow","volume":"17","author":"Saito","year":"2015","journal-title":"Cell Stem Cell"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/ncb2432","article-title":"Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukemia","volume":"14","author":"Zhang","year":"2012","journal-title":"Nat. Cell Biol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.4161\/15384101.2014.964107","article-title":"The metabolically modulated stem cell niche: A dynamic scenario that regulates cancer cell phenotype and resistance to therapy","volume":"13","author":"Rovida","year":"2014","journal-title":"Cell Cycle"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13287-017-0755-3","article-title":"High-throughput immunophenotypic characterization of bone marrow-derived mesenchymal stromal cells and umbilical cord blood reveals common and differentially expressed markers: Identification of angiotensin-converting enzyme (CD143) as a differentially expressed marker between adult and perinatal tissue sources","volume":"9","author":"Amati","year":"2018","journal-title":"Stem Cell Res. Ther."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s12072-014-9536-6","article-title":"Upregulation of CD147 protects hepatocellular carcinoma cells from apoptosis through glycolytic switch via HIF-1 and MCT-4 in hypoxia","volume":"8","author":"Ke","year":"2014","journal-title":"Hepatol. Int."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Bougatef, F., Menashi, S., Khayati, F., Na\u00efmi, B., Porcher, R., Podgorniak, M.P., Millot, G., Janin, A., Calvo, F., and Lebb\u00e9, C. (2010). EMMPRIN promotes the malignant properties of melanoma cells through HIF-2alpha-mediated upregulation of the VEGF-2 receptor. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0012265"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/art.34341","article-title":"CD147 induces angiogenesis through a vascular endothelial growth factor and a hypoxia-inducible transcription factor 1\u03b1-mediated pathway in rheumatoid arthritis","volume":"64","author":"Wang","year":"2012","journal-title":"Arthritis Rheum."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.1182\/blood-2009-04-217380","article-title":"EMMPRIN promotes angiogenesis through hypoxia-inducible factor-2-mediated regulation of soluble VEGF isoforms and their fu fuR-2 receptor","volume":"114","author":"Bougatef","year":"2009","journal-title":"Blood"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"82803","DOI":"10.18632\/oncotarget.20294","article-title":"Monocarboxylate transporter 1 (MCT1), a tool to stratify patients with acute myeloid leukemia (AML) and a vehicle to kill cancer cells","volume":"8","author":"Nunes","year":"2017","journal-title":"Oncotarget"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Ishihara, S., Hata, K., Hirose, K., Okui, T., Toyosawa, S., Uzawa, N., Nishimura, R., and Yoneda, T. (2022). The GPR81 lactate sensor regulates the glycolysis and tumor growth of breast cancer. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-10143-w"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1038\/s41388-020-1216-5","article-title":"The lactate receptor GPR81 promotes breast cancer growth via a paracrine mechanism involving antigen-presenting cells in the tumor microenvironment","volume":"39","author":"Brown","year":"2020","journal-title":"Oncogene"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Soto, C.A., Lesch, M.L., Sharipol, A., Khan, A., Schafer, L.X., Becker, M.W., Munger, J.C., and Frisch, B.J. (2023). Elevated Lactate in Acute Myeloid Leukemia Bone Marrow Microenvironment Dysfunction, with a Dual Role of GPR81 in Macrophage Polarization and Leukemia Cell Growth. BioRxiv, 11.13.566874.","DOI":"10.1016\/j.jbo.2024.100575"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/nbt1350","article-title":"Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region","volume":"25","author":"Ishikawa","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A cell initiating human acute myeloid leukaemia after transplantation into SCID mice","volume":"367","author":"Lapidot","year":"1994","journal-title":"Nature"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.cmet.2020.07.009","article-title":"Induction of a timed metabolic collapse to overcome cancer chemoresistance","volume":"32","author":"Spinelli","year":"2020","journal-title":"Cell Metab."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1182\/blood-2013-07-511907","article-title":"Physiologic hypoxia promotes maintenance of CML stem cells despite effective BCR-ABL1 inhibition","volume":"123","author":"Ng","year":"2014","journal-title":"Blood"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s12013-014-0270-4","article-title":"shRNA-mediated EMMPRIN silencing inhibits human leukemic monocyte lymphoma U937 cell proliferation and increases chemosensitivity to adriamycin","volume":"71","author":"Gao","year":"2015","journal-title":"Cell Biochem. Biophys."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1742-2094-9-64","article-title":"A novel anti-EMMPRIN function-blocking antibody reduces T cell proliferation and neurotoxicity: Relevance to multiple sclerosis","volume":"9","author":"Agrawal","year":"2012","journal-title":"J. Neuroinflamm."},{"key":"ref_134","first-page":"33","article-title":"Involvement of CD147 on multidrug resistance through the regulation of P-glycoprotein expression in K562\/ADR leukemic cell line","volume":"6","author":"Somno","year":"2016","journal-title":"Leuk. Res. Rep."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"e1261778","DOI":"10.1080\/2162402X.2016.1261778","article-title":"Inhibition of tumor growth and metastasis by EMMPRIN multiple antigenic peptide (MAP) vaccination is mediated by immune modulation","volume":"6","author":"Simanovich","year":"2016","journal-title":"Oncoimmunology"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/intimm\/11.5.777","article-title":"T cell activation-associated epitopes of CD147 in regulation of the T cell response, and their definition by antibody affinity and antigen density","volume":"11","author":"Koch","year":"1999","journal-title":"Int. Immunol."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Wang, R., Zong, K., Song, J., Song, Q., Xia, D., Liu, M., Du, H., Xia, Z., Yao, H., and Han, J. (2023). Inhibitor of CD147 Suppresses T Cell Activation and Recruitment in CVB3-Induced Acute Viral Myocarditis. Viruses, 15.","DOI":"10.3390\/v15051137"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1089\/hyb.2006.25.60","article-title":"Regulation of matrix metalloproteinase production and tumor cell invasion by four monoclonal antibodies against different epitopes of HAb18G\/CD147 extracellular domain","volume":"25","author":"Wang","year":"2006","journal-title":"Hybridoma"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ijrobp.2005.12.034","article-title":"Targeting radioimmunotherapy of hepatocellular carcinoma with iodine (131I) metuximab injection: Clinical phase I\/II trials","volume":"65","author":"Chen","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_140","first-page":"1","article-title":"Downregulation of extracellular matrix metalloproteinase inducer by scFv-M6-1B9 intrabody suppresses cervical cancer invasion through inhibition of urokinase-type plasminogen activator","volume":"32","author":"Panich","year":"2017","journal-title":"Cancer Biother. Radiopharm."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1158\/1535-7163.MCT-14-0104","article-title":"Preclinical pharmacokinetics, tolerability, and pharmacodynamics of metuzumab, a novel CD147 human-mouse chimeric and glycoengineered antibody","volume":"14","author":"Zhang","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Bl\u00fcm, P., and Kayser, S. (2024). Chimeric Antigen Receptor (CAR) T-Cell Therapy in Hematologic Malignancies: Clinical Implications and Limitations. Cancers, 16.","DOI":"10.3390\/cancers16081599"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"215762","DOI":"10.1016\/j.canlet.2022.215762","article-title":"CD147-specific chimeric antigen receptor T cells effectively inhibit T cell acute lymphoblastic leukemia","volume":"542","author":"Zheng","year":"2022","journal-title":"Cancer Lett."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1038\/leu.2011.144","article-title":"Cooperative roles for emmprin and LYVE-1 in the regulation of chemoresistance for primary effusion lymphoma","volume":"25","author":"Qin","year":"2011","journal-title":"Leukemia"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/17\/9178\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:42:32Z","timestamp":1760110952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/17\/9178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,23]]},"references-count":144,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["ijms25179178"],"URL":"https:\/\/doi.org\/10.3390\/ijms25179178","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,23]]}}}